Clinical trial · Observational
AI Models for Predicting Occult Pleural Dissemination in NSCLC
Comparing Radiomics, Deep Learning, and Fusion Models for Predicting Occult Pleural Dissemination in Patients With Non-small Cell Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Occult pleural dissemination (PD) in non-small cell lung cancer (NSCLC) patients is likely to be missed on computed tomography (CT) scans, associated with poor survival, and generally contraindicated for radical surgery. This study aimed to develop and compare the performance of radiomics-based machine learning (ML), deep learning (DL), and fusion models to preoperatively identify occult PDs in NSCLC patients. Patients from three Chinese high-volume medical centers (2016-2023) were retrospectively collected and divided into training, internal test, and external test cohorts. Ten radiomics-based ML models and eight DL models were trained using CT plain scan images at the maximum cross-sectional areas of the primary tumor. Moreover, another two fusion models (prefusion and postfusion) were developed using feature-based and decision-based methods. The receiver operating characteristic curve (ROC) and area under the curve (AUC) were mainly used to compare the predictive performance of the models.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- non-small cell lung cancer (NSCLC) patients with or without occult pleural dissemination.
Primary outcomes (1)
- measure
- The area under the receiver operating characteristic curve (AUC)
- timeFrame
- through study completion, an average of 6 months.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * pathologically confirmed primary NSCLC with malignant pleural dissemination; * no preoperative treatment; * clinicopathological data were complete. Exclusion Criteria: * pleural effusion detected preoperatively; * preoperatively diagnosed with PD; * poor CT quality or no CT scans within 1 month before surgery.
References
Publications (0)
Data not yet available